We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a look…
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., January 17, 2025–Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy, cardiometabolic disorders,…
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and it’s making itself felt all across the field of companies selling…
We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look…
Key Insights Using the 2 Stage Free Cash Flow to Equity, LifeMD fair value estimate is US$9.77 LifeMD is estimated to…
Shares of several obesity drugmakers dip after LLY lowered its revenue outlook for 2024 amid slower-than-expected sales growth of its tirzepatide products in Q4.
Investors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three years
It might be of some concern to shareholders to see the Hims & Hers Health, Inc. ( NYSE:HIMS ) share price down 16% in…
Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January…
Xponential Fitness Announces Executive Leadership Appointments
IRVINE, Calif., January 15, 2025–Xponential Fitness, Inc. (NYSE: XPOF) (the “Company” or “Xponential Fitness”), one of the leading global franchisors of boutique health and wellness…
Executives at Amgen made the case for MariTide’s differentiation, while Merck’s CEO contended that Keytruda’s coming loss of exclusivity can be managed.
Bad news for Eli Lilly (NYSE: LLY) stock dragged down shares of rival companies in the market for GLP-1 diet drugs on Tuesday. Lilly updated…
3 US Penny Stocks With Market Caps Under $200M To Consider
The U.S. stock market has shown resilience, with the Dow Jones Industrial Average rising on a softer-than-expected Producer Price Index report and a dip in…